FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,297,896 | -55.5% | 612,215 | 0.0% | 0.04% | -49.3% |
| Q2 2023 | $2,914,143 | -16.5% | 612,215 | 0.0% | 0.07% | -16.9% |
| Q1 2023 | $3,489,626 | +214.4% | 612,215 | +456.6% | 0.08% | +207.4% |
| Q4 2022 | $1,109,900 | -55.0% | 110,000 | 0.0% | 0.03% | -57.8% |
| Q3 2022 | $2,465,000 | -9.6% | 110,000 | 0.0% | 0.06% | -19.0% |
| Q2 2022 | $2,726,000 | -36.1% | 110,000 | 0.0% | 0.08% | -26.2% |
| Q1 2022 | $4,265,000 | -33.7% | 110,000 | 0.0% | 0.11% | -28.2% |
| Q4 2021 | $6,436,000 | -1.3% | 110,000 | 0.0% | 0.15% | +8.8% |
| Q3 2021 | $6,520,000 | +7.3% | 110,000 | +57.1% | 0.14% | +14.2% |
| Q2 2021 | $6,075,000 | +5.2% | 70,000 | 0.0% | 0.12% | -4.8% |
| Q1 2021 | $5,772,000 | – | 70,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |